About TMS Therapy

Quick Guide: 10 Things to Know About TMS Therapy

Essential information about Greenbrook TMS therapy

Learn More with our Quick Guide fact sheet >

Indications

TMS Therapy is FDA-cleared for Major Depression Disorder & Obsessive Compulsive Disorder after an individual has failed 1 antidepressant of a high enough dose & duration. 

Learn more with our Indications fact sheet >

Mechanism of Action

TMS therapy for the treatment of depression works by placing MRI-strength magnetic coil over the dorsolateral prefrontal cortex. The coil delivers magnetic pulses into the brain, activating neurons in the areas of the brain responsible for mood regulation. Pulses trigger magnetic currents that release neurotransmitters, helping with neuroplasticity without the systemic side effects that can come with medications.

Learn more with our Mechanisms of Action fact sheet >

Patient Selection & Treatment Process

TMS is non-systemic, non-invasive, and can be used as an adjunct therapy or as monotherapy, so a wide range of patients with Major Depressive Disorder can benefit from Greenbrook TMS therapy. 

Learn more with our Patient Selection Criteria fact sheet > 

Typical Course of treatment for Greenbrook TMS therapy is 20-40 minutes per treatment, 5 days a week for 6 weeks & a 2-3 week treatment tapering period (average of 30 treatments total).

Learn more with our Greenbrook Patient Process fact sheet >

Comparing Options for Treatment-Resistant Depression

Once a patient has failed 2 medication trials or isn't responding as well as you'd hoped, there are other options for treatment beyond testing more medication trials. See how TMS therapy compares to electro-convulsive therapy & esketamine nasal spray.

Learn more with our Options for Treatment-Resistant Depression fact sheet >

More details on our Options for Treatment-Resistant Depression trifold >

TMS Therapy Studies

Major findings include: 
- TMS Therapy has proven durability measured over 12 months
- Medication management has limited effectiveness as trials progress
Likelihood of discontinuing treatment because of side effects increases with each new medication attempt

Learn more with the TMS Therapy Studies fact sheet >

Medication Side Effects and Discontinuation

Click here for all printable resources > 

Learn via Video

About Greenbrook TMS



TMS Mechanism of Action

Patient Treatment Customization

 

Greenbrook TMS Insurance Coverage

TMS Patient Case Examples

 

CEU/CME Opportunities

WEBINAR:
What's Shakin':
 Brain Stimulation Therapies for Psychiatric Disorders

Presenter: 
Dr. Steve Harvey, St. Louis Regional Medical Director

Date & Times: 
Saturday, June 6th at 8:00 AM CST
Tuesday, June 16th at 12:00 PM CST